RESISTANCE-ASSOCIATED SUBSTITUTIONS AFTER TRIPLE THERAPY (SOFOSBUVIR/VELPATASVIR/VOXILAPREVIR) TREATMENT FAILURES
收藏NIAID Data Ecosystem2026-03-12 收录
官方服务：
资源简介：
Characterization of the RAS in patients before begin the triple therapy (SOF+VEL+VOXI) treatment, and they prevalence at the end of treatment.
创建时间：
2020-09-08
相关数据集
暂无相关数据集
